P2RY12 and acute coronary syndrome: Dual antiplatelet treatment (DAPT), consisting in the combination of aspirin and a P2Y12 inhibitor, represents the antithrombotic regimen of choice for the prevention of thrombotic complications in patients with acute coronary syndrome (ACS) as well as for those undergoing percutaneous coronary intervention (PCI) (1).